May 08, 2007
Less than six months after the Thai public health ministry said it would issue a compulsory licence over a patent held by Merck for the AIDS treatment drug efavirenz, the Brazilian government has followed suit
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2020 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International